Safety and Efficacy of Pembrolizumab, Radiation Therapy, and Surgery versus Radiation Therapy and Surgery for Stage III Soft Tissue Sarcoma of the Extremity (SU2C-SARC032): An Open-Label, Randomised Clinical Trial.|Citation only
Safety and Efficacy of Pembrolizumab, Radiation Therapy, and Surgery versus Radiation Therapy and Surgery for Stage III Soft Tissue Sarcoma of the Extremity (SU2C-SARC032): An Open-Label, Randomised Clinical Trial.|Citation only